Companies
Companies

Exciting Collaboration Boosts Excellos’ Cell Therapy!
📣 CDMO Excellos teams up with Vitalant for cell therapy advancements! 💉🧪 Excellos' programs will benefit from Vitalant's services, boosting their biotech offerings. 🚀

Oligo Factory MA Plant Gets GMP Greenlight!
🌱 Exciting news! The Oligo Factory MA plant 🏭 has received the GMP greenlight 💚 for biotech industry. Get ready for innovation! 🚀

Major Leadership Changes in Oncology Biotechs: What’s Next?
📰 Ins & Outs: C-suite changes across oncology biotechs explores recent leadership transitions in cancer-focused biotech companies. 👥🌟🏥🧪🔬

Breaking: CGTs Accessibility Challenges Uncovered in 2023
📰CGTs in 2023: Floodgates open but patient access still sticky highlights challenges in patient access to CGTs. 👥💡💰⚕️🤝🌍

Lonza shuts down Swiss manufacturing site cutting 190 jobs
📢 Lonza is decommissioning its mammalian manufacturing site in Visp, Switzerland, after 30 years of operation. 🏭✅ This decision is driven by market dynamics and the need for flexibility. ❌ However, Lonza will focus on other sites and genecell therapies. 😔 Around 190 jobs will be lost.

Revolutionary Partnership Boosts Spider Silk Production
🌐 AMSilk GmbH and 21st.BIO AS are partnering to accelerate the production of spider silk-based proteins. 🔬💡👟

Celltrion’s Game-Changing 5-Year Partnership Boosts Biotech
📢 Celltrion taps Prestige Bio in a 5-year CDMO deal, expanding its capabilities and strengthening its global position. 💼🌐💪📈

CordenPharma Revolutionizes Drug Delivery with pHLIP LNP Platform
💼 CordenPharma partners with pHLIP LNP platform to revolutionize drug delivery and expand capabilities in biotechnology. 🚀💊🤝

Pluri Revolutionizes Cell Therapy with Expanded CDMO Services
🌟 Pluri, a cell therapy pioneer, ventures into the CDMO space, offering end-to-end services for biotech development. 🚀

Sleep Tech Startup Onera Health Raises $32M in Funding
📢 Sleep diagnostics specialist Onera Health raises €30m ($32m) in Series C round, accelerating manufacturing and expanding devices. 💤💰





